跳至主要内容
临床试验/JPRN-UMIN000007037
JPRN-UMIN000007037尚未招募未知

QUalification of Efficacy in the study of intENsive care with Tolvaptan - QUEEN trial

Division of Cardiovascular Medicine , Department of Internal Medicine,Kobe University Graduate School of Medicine0 个研究点目标入组 54 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Acute myocardial infarction 2.Patients with circulatory assist device 3.Severe hypotension or cardiogenic shock 4.Patients are considered undesirable rapid decrease in blood flow circulation 5.Patients with right heart ventricular infarction 6.Activ form of myocarditis 7.Patients with dehydration 8.Total bilirubin>3.0mg/dL 9.Serum K>5.5mEq/L 10.Serum K>5.5mEq/L 11.Patietns with hypersensitivity to study drug 12.Anuric patients 13.Insensitivity to the thirst or difficult for the water intake 14.Hypernatremia (serum Na>147mEq/L) 15.Pregnant woman, lactational woman, patients may be willing to be pregnant or are pregnant 16.In addition, patients were judged as inadequate by physician

研究者

发起方
Division of Cardiovascular Medicine , Department of Internal Medicine,Kobe University Graduate School of Medicine

相似试验